Andre R. Kydd

POTE Paralogs Are Induced and Differentially Expressed in Many Cancers

Tapan K. Bera, Ashley Saint Fleur, Yoomi Lee et al. · Cancer Research · 2006 · 69 citations

Life Sciences, Cell Biology, Oncology +6

Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors

Andrea B. Apolo, Daniel M. Girardi, Scot A. Niglio et al. · Journal of Clinical Oncology · 2024 · 24 citations · Full text

Medicine, Oncology, Pharmacology +15

Negative regulation of the SH2-homology–containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein

Jihua Cheng, Andre R. Kydd, Koichi Nakase et al. · Blood · 2007 · 23 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

SMART: A phase II study of sacituzumab govitecan (SG) with or without atezolizumab immunotherapy in rare genitourinary (GU) tumors such as small cell, adenocarcinoma, and squamous cell bladder/urinary tract cancer, renal medullary carcinoma (RMC) and penile cancer.

Andre R. Kydd, Elias Chandran, Nicholas I. Simon et al. · Journal of Clinical Oncology · 2024 · 10 citations

Medicine, Oncology, Pharmacology +17